Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 3.43% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 3.43% | -- | -- | -- | |
| Cost of Revenue | 18.31% | -- | -- | -- | |
| Gross Profit | 3.00% | -- | -- | -- | |
| SG&A Expenses | -2.89% | -- | -- | -- | |
| Depreciation & Amortization | -32.69% | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -4.56% | -- | -- | -- | |
| Operating Income | 36.44% | -- | -- | -- | |
| Income Before Tax | 43.01% | -- | -- | -- | |
| Income Tax Expenses | 30.07% | -- | -- | -- | |
| Earnings from Continuing Operations | 45.93% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 54.15% | -- | -- | -- | |
| EBIT | 36.44% | -- | -- | -- | |
| EBITDA | 19.10% | -- | -- | -- | |
| EPS Basic | 53.94% | -- | -- | -- | |
| Normalized Basic EPS | 53.68% | -- | -- | -- | |
| EPS Diluted | 53.94% | -- | -- | -- | |
| Normalized Diluted EPS | 53.68% | -- | -- | -- | |
| Average Basic Shares Outstanding | 0.00% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 0.00% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |